BRXTX
Price
$20.35
Change
+$0.21 (+1.04%)
Updated
Jun 2 closing price
Net Assets
4.85B
FSGEX
Price
$21.20
Change
+$0.16 (+0.76%)
Updated
Jun 2 closing price
Net Assets
74.28B
Interact to see
Advertisement

BRXTX vs FSGEX

Header iconBRXTX vs FSGEX Comparison
Open Charts BRXTX vs FSGEXBanner chart's image
BRXTX vs FSGEX Comparison Chart in %
View a ticker or compare two or three
VS
BRXTX vs. FSGEX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRXTX is a StrongBuy and FSGEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSGEX has more cash in the bank: 74.3B vs. BRXTX (4.85B). FSGEX pays higher dividends than BRXTX: FSGEX (2.64) vs BRXTX (1.23). BRXTX was incepted earlier than FSGEX: BRXTX (11 years) vs FSGEX (17 years). BRXTX (0.78) is less costly to investors than FSGEX (0.01). BRXTX is a more actively managed with annual turnover of: 48.00 vs. FSGEX (8.00). BRXTX (0) and FSGEX (0) have matching initial minimum investment requirements. BRXTX annual gain was more profitable for investors over the last year : 34.58 vs. FSGEX (32.37). BRXTX return over 5 years is better than : 62.70 vs. FSGEX (53.10).
BRXTXFSGEXBRXTX / FSGEX
Total Expense Ratio0.770.017,700%
Annual Report Gross Expense Ratio0.780.017,800%
Fund Existence11 years17 years-
Gain YTD16.14814.973108%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets4.85B74.3B7%
Annual Yield % from dividends1.232.6446%
Returns for 1 year34.5832.37107%
Returns for 3 years84.8272.19117%
Returns for 5 years62.7053.10118%
Returns for 10 years155.41141.45110%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPHA1.820.04
+2.25%
Innate Pharma SA
LRN97.911.41
+1.46%
Stride
CRCT4.16-0.23
-5.24%
Cricut
RVMD151.30-12.38
-7.56%
Revolution Medicines
HCWB1.79-0.28
-13.53%
HCW Biologics Inc